Northern Trust’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.7M Sell
3,089,806
-285,320
-8% -$1.63M ﹤0.01% 1714
2025
Q1
$27.5M Buy
3,375,126
+3,487
+0.1% +$28.5K ﹤0.01% 1438
2024
Q4
$31.8M Buy
3,371,639
+187,652
+6% +$1.77M ﹤0.01% 1416
2024
Q3
$34M Buy
3,183,987
+136,633
+4% +$1.46M 0.01% 1287
2024
Q2
$30.2M Sell
3,047,354
-108,728
-3% -$1.08M 0.01% 1297
2024
Q1
$37.2M Buy
3,156,082
+311,331
+11% +$3.67M 0.01% 1192
2023
Q4
$40.4M Buy
2,844,751
+12,821
+0.5% +$182K 0.01% 1156
2023
Q3
$34.4M Buy
2,831,930
+15,608
+0.6% +$190K 0.01% 1177
2023
Q2
$35.4M Buy
2,816,322
+99,488
+4% +$1.25M 0.01% 1199
2023
Q1
$30.1M Buy
2,716,834
+19,261
+0.7% +$214K 0.01% 1288
2022
Q4
$32.9M Buy
2,697,573
+33,885
+1% +$414K 0.01% 1195
2022
Q3
$27.8M Sell
2,663,688
-30,413
-1% -$318K 0.01% 1246
2022
Q2
$28.9M Buy
2,694,101
+5,461
+0.2% +$58.7K 0.01% 1280
2022
Q1
$25.5M Sell
2,688,640
-106,397
-4% -$1.01M ﹤0.01% 1505
2021
Q4
$32.3M Sell
2,795,037
-35,963
-1% -$415K 0.01% 1434
2021
Q3
$27M Sell
2,831,000
-124,285
-4% -$1.19M ﹤0.01% 1570
2021
Q2
$28.5M Sell
2,955,285
-5,431
-0.2% -$52.4K 0.01% 1635
2021
Q1
$29.3M Sell
2,960,716
-265,189
-8% -$2.62M 0.01% 1555
2020
Q4
$74.5M Sell
3,225,905
-78,592
-2% -$1.81M 0.01% 800
2020
Q3
$46.7M Sell
3,304,497
-205,250
-6% -$2.9M 0.01% 968
2020
Q2
$52.9M Buy
3,509,747
+142,231
+4% +$2.14M 0.01% 849
2020
Q1
$31.1M Buy
3,367,516
+38,667
+1% +$357K 0.01% 1094
2019
Q4
$32.4M Buy
3,328,849
+70,440
+2% +$686K 0.01% 1349
2019
Q3
$26.1M Buy
3,258,409
+598,798
+23% +$4.8M 0.01% 1467
2019
Q2
$33.2M Buy
2,659,611
+136,521
+5% +$1.7M 0.01% 1315
2019
Q1
$34.3M Buy
2,523,090
+80,700
+3% +$1.1M 0.01% 1274
2018
Q4
$23.4M Sell
2,442,390
-3,487
-0.1% -$33.4K 0.01% 1449
2018
Q3
$29.6M Buy
2,445,877
+51,387
+2% +$621K 0.01% 1467
2018
Q2
$37.4M Buy
2,394,490
+203,444
+9% +$3.18M 0.01% 1266
2018
Q1
$33M Buy
2,191,046
+219,558
+11% +$3.3M 0.01% 1319
2017
Q4
$28.4M Sell
1,971,488
-5,371
-0.3% -$77.3K 0.01% 1439
2017
Q3
$29.8M Buy
1,976,859
+238,849
+14% +$3.6M 0.01% 1391
2017
Q2
$17.5M Buy
1,738,010
+52,569
+3% +$529K ﹤0.01% 1771
2017
Q1
$12M Buy
1,685,441
+71,599
+4% +$510K ﹤0.01% 1987
2016
Q4
$8.02M Buy
1,613,842
+13,726
+0.9% +$68.2K ﹤0.01% 2249
2016
Q3
$11.8M Buy
1,600,116
+164,436
+11% +$1.22M ﹤0.01% 1954
2016
Q2
$7.84M Buy
1,435,680
+118,138
+9% +$645K ﹤0.01% 2181
2016
Q1
$11.1M Buy
1,317,542
+19,034
+1% +$161K ﹤0.01% 1896
2015
Q4
$12.6M Buy
1,298,508
+34,967
+3% +$339K ﹤0.01% 1832
2015
Q3
$17.7M Buy
1,263,541
+1,019,446
+418% +$14.3M 0.01% 1584
2015
Q2
$3.45M Buy
244,095
+78,941
+48% +$1.12M ﹤0.01% 2755
2015
Q1
$1.8M Buy
165,154
+18,149
+12% +$197K ﹤0.01% 3179
2014
Q4
$1.22M Buy
147,005
+58,347
+66% +$485K ﹤0.01% 3327
2014
Q3
$528K Sell
88,658
-236,266
-73% -$1.41M ﹤0.01% 3552
2014
Q2
$1.09M Sell
324,924
-76,526
-19% -$256K ﹤0.01% 3365
2014
Q1
$831K Sell
401,450
-25,142
-6% -$52K ﹤0.01% 3435
2013
Q4
$1M Buy
426,592
+4,358
+1% +$10.2K ﹤0.01% 3378
2013
Q3
$979K Sell
422,234
-4,264
-1% -$9.89K ﹤0.01% 3335
2013
Q2
$993K Buy
+426,498
New +$993K ﹤0.01% 3275